Advertisement

Low doses of clozapine may stabilize treatment–resistant bipolar patients

  • B. S. Fehr
  • M. E. Ozcan
  • T. Suppes
ORIGINAL PAPER

Abstract

Open, uncontrolled studies suggest clozapine can have mood–stabilizing effects in treatment–resistant bipolar disorder. Unfortunately, the side effect profile limits clozapine’s use at high doses. We report a series of nine bipolar I disorder patients who improved on relatively low doses of clozapine add–on therapy (250 mg or lower). Retrospectively abstracted clinical data identified nine patients with bipolar I disorder, as defined by DSMIV criteria, treated with low–dose clozapine at inpatient and outpatient settings. Monthly symptom evaluations were collected prospectively using standard assessments. Symptoms of mania and mood lability improved in all patients. Three patients demonstrated striking mood stabilization and returned to previous levels of functioning; five patients evidenced moderate improvement in mood stabilization and functioning; and one patient showed a minimal response. Overall, clozapine did not have a significant antidepressant effect. The mean clozapine dose at the end of the study was 156.3 ± 77.6 mg/day, and duration of treatment was 12 months. Residual side effects were mild. The symptomatic improvement in these prospectively evaluated patients is consistent with our clinical impression in the majority of patients with bipolar disorder taking clozapine.

Key words

clozapine bipolar disorder efficacy side effects treatment–resistant combination treatment 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    American Psychiatric Association (2002) Practice guideline for the treatment of patients with bipolar disorder (Revision). Am J Psychiatry 159(suppl 4):1–50Google Scholar
  2. 2.
    Angst J, Gamma A, Sellaro R, Lavori PW, Zhang H (2003) Recurrence of bipolar disorders and major depression. A lifelong perspective. Eur Arch Psychiatry Clin Neurosci 253:236–240CrossRefPubMedGoogle Scholar
  3. 3.
    Baker RW, Chengappa KNR, Baird JW (1992) Emergence of obsessive- compulsive symptoms during treatment with clozapine. J Clin Psychiatry 53:439–442PubMedGoogle Scholar
  4. 4.
    Banov MD, Zarate CA Jr, Tohen M, Scialabba D, Wines JD Jr, Kolbrener M, Kim JW, Cole JO (1994) Clozapine therapy in refractory affective disorders: polarity predicts response in long-term follow-up. J Clin Psychiatry 55:295–300PubMedGoogle Scholar
  5. 5.
    Bech P, Bolwig TG, Kramp T, Rafaelsen OJ (1979) The Bech- Rafaelsen Mania Scale and the Hamilton Depression Scale: Evaluation of homogeneity and inter-observer reliability. Acta Psychiatr Scand 59:420PubMedGoogle Scholar
  6. 6.
    Brown ES, Thomas NR, Carmody T,Mahadi S, Nejtek VA (2001) Atypical antipsychotics in bipolar and schizoaffective disorders. Pharmacopsychiatry 34:80–81CrossRefPubMedGoogle Scholar
  7. 7.
    Calabrese JR, Kimmel SE, Woyshville MJ, Rapport DJ, Faust CJ, Thompson PA, Meltzer HY (1996) Clozapine for treatment-refractory mania. Am J Psychiatry 153:759–764PubMedGoogle Scholar
  8. 8.
    Calabrese JR, Meltzer HY, Markowitz PJ (1991) Clozapine prophylaxis in rapid cycling bipolar disorder. J Clin Psychopharmacol 11:396–397PubMedGoogle Scholar
  9. 9.
    Chengappa KN, Baker RW, Kreinbrook SB, Adair D (1995) Clozapine use in female geriatric patients with psychoses. J Geriatr Psychiatr Neurol 8:12–15Google Scholar
  10. 10.
    Frankenburg F (1993) Clozapine and bipolar disorder. J Clin Psychopharmacol 13:289–290PubMedGoogle Scholar
  11. 11.
    Frye MA, Ketter TA, Altshuler LL, Denicoff K, Dunn RT, Kimbrell TA, Cora-Locatelli G, Post RM (1998) Clozapine in bipolar disorder: treatment implications for other atypical antipsychotics. J Affect Disord 48:91–104PubMedGoogle Scholar
  12. 12.
    Fuchs DC (1994) Clozapine treatment of bipolar disorder in a young adolescent. J Am Acad Child Adolesc Psychiatry 33:1299–1302Google Scholar
  13. 13.
    Gaebel W, Riesbeck M, Janssen B, Schneider F, Held T, Macklenburg H, Sass H (2003) Atypical and typical neuroleptics in acute schizophrenia and related delusional disorders. Drug choice, switching and outcome under naturalistic treatment conditions. Eur Arch Psychiatry Clin Neurosci 253:175–184CrossRefPubMedGoogle Scholar
  14. 14.
    Guille C, Sachs GS, Ghaemi SN (2000) A naturalistic comparison of clozapine, risperidone, and olanzapine in the treatment of bipolar disorder. J Clin Psychiatry 61:638–642PubMedGoogle Scholar
  15. 15.
    Hamilton M (1960) Rating scale for depression. J Neurol Neurosurg Psychiatry 23:56Google Scholar
  16. 16.
    Kane J, Honigfeld G, Singer J, Meltzer HY (1988) Clozapine for the treatment-resistant schizophrenic. A double-blinded comparison with chlorpromazine. Arch Gen Psychiatry 45:789–796PubMedGoogle Scholar
  17. 17.
    Kowatch RA, Suppes T, Gilfillan SK, Fuentes RM (1995) Clozapine treatment of children and adolescents with bipolar disorder and schizophrenia. A clinical case series. J Child Adolesc Psychopharmacol 5:241–253Google Scholar
  18. 18.
    McElroy SL, Dessain EC, Pope HG, Cole JO, Keck PE Jr, Frankenberg FR, Aizley HG, O’Brien S (1991) Clozapine in the treatment of psychotic mood disorders,schizoaffective disorder,and schizophrenia. J Clin Psychiatry 52:411–414PubMedGoogle Scholar
  19. 19.
    Naber D, Holzbach R, Perro C, Hippius H (1992) Clinical management of clozapine patients in relation to efficacy and side effects. Br J Psychiatry 160(suppl 17):54–59Google Scholar
  20. 20.
    Oberholzer AF, Hendriksen C, Monsch AU, Heierli B, Stahelin HB (1992) Safety and effectiveness of low-dose clozapine in psychogeriatric patients: a preliminary study. Int Psychogeriatr 4:187–195CrossRefPubMedGoogle Scholar
  21. 21.
    Overall JE, Gorham DR (1962) The Brief Psychiatric Rating Scale (BPRS). Psycho Rep 1:799Google Scholar
  22. 22.
    Patel B, Tandon R (1993) Development of obsessive-compulsive symptoms during clozapine treatment. Am J Psychiatry 150:836Google Scholar
  23. 23.
    Patel VJ (1992) Development of transient obsessive-compulsive symptoms during treatment with clozapine. Am J Psychiatry 149:272Google Scholar
  24. 24.
    Privitera MR, Lamberti JS,Maharaj K (1993) Clozapine in a bipolar depressed patient. Am J Psychiatry 150:986Google Scholar
  25. 25.
    Puri BK, Taylor DG, Alcock ME (1995) Low-dose maintenance clozapine treatment in the prophylaxis of bipolar affective disorder. Br J Clin Pract 49:333–334PubMedGoogle Scholar
  26. 26.
    Rabey JM, Treves TA, Neufeld MY, Orlov E, Korczyn AD (1995) Low-dose clozapine in the treatment of levodopa-induced mental disturbances in Parkinson’s disease. Neurology 45:432–434PubMedGoogle Scholar
  27. 27.
    Seeman P (1992) Dopamine receptor sequences: therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261–284Google Scholar
  28. 28.
    Shelton RC, Tollefson GD, Tohen M, Stahl S, Gannon KS, Jacobs TG, Buras WR, Bymaster FP, Zhang W, Spencer KA, Feldman PD, Meltzer HY (2001) A novel augmentation strategy for treating resistant major depression. Am J Psychiatry 158:131–134CrossRefPubMedGoogle Scholar
  29. 29.
    Shopsin B, Klein H, Aaronson M, Collora M (1979) Clozapine, chlorpromazine, and placebo in newly hospitalized acutely schizophrenic patients. A controlled, double-blind comparison. Arch Gen Psychiatry 36:657–664PubMedGoogle Scholar
  30. 30.
    Spitzer RL, Williams JBW, Gibbon M, First MB (1992) The Structured Clinical Interview for DSM-III-R (SCID), I: history, rationale, and description. Arch Gen Psychiatry 49:624–629PubMedGoogle Scholar
  31. 31.
    Suppes T, Mc Elroy SL, Gilbert G, Dessain EC, Cole JO (1992) Clozapine in the treatment of dysphoric mania. Biol Psychiatry 32:270–280CrossRefPubMedGoogle Scholar
  32. 32.
    Suppes T, Phillips K, Judd C (1994) Clozapine treatment of nonpsychotic rapid cycling bipolar disorder. A report of three cases. Biol Psychiatry 3:338–340CrossRefGoogle Scholar
  33. 33.
    Suppes T, Rush JA (1996) Medication optimization during clozapine treatment. J Clin Psychiatry 57:307–308Google Scholar
  34. 34.
    Suppes T, Webb A, Paul B,Carmody T, Kraemer H, Rush AJ (1999) Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania. Am J Psychiatry 156:1164–1169PubMedGoogle Scholar
  35. 35.
    Weizman R, Weizman A (2001) Use of atypical antipsychotics in mood disorders. Curr Opin Investig Drugs 2:940–945PubMedGoogle Scholar
  36. 36.
    Wolk SI, Douglas CJ (1992) Clozapine treatment of psychosis in Parkinson’s disease: a report of five consecutive cases. J Clin Psychiatry 53:373–376PubMedGoogle Scholar
  37. 37.
    Zarate CA, Tohen M, Banov MD, Weiss MK, Cole JO (1995) Is clozapine a mood stabilizer? J Clin Psychiatry 56:108–112PubMedGoogle Scholar

Copyright information

© Steinkopff Verlag 2004

Authors and Affiliations

  1. 1.VA HospitalThe University of Texas Southwestern Medical CenterDallasUSA
  2. 2.Bipolar Disorder Research ProgramDepartment of Psychiatry The University of Texas Southwestern Medical CenterDallas TX 75390-9121USA

Personalised recommendations